Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Influenza
Meningococcal disease
NITAG documentation
2015
Clear all
Type of publications
NITAG documentation
(23)
SAGE documentation
(5)
Scientific publications
(2)
Systematic reviews (SYSVAC)
(20)
Topics
Background paper
(8)
Recommendation
(15)
Available to download in languages
English (EN)
(16)
French (FR)
(10)
Regions
Americas
(13)
Europe
(9)
Western Pacific
(1)
Countries
Diseases
Influenza
(14)
Meningococcal disease
(9)
Diphtheria
(1)
Haemophilus influenzae type B
(3)
Hepatitis A
(4)
Hepatitis B
(3)
Human papillomavirus (HPV)
(15)
Measles
(3)
Pertussis
(4)
Pneumococcal disease
(5)
Poliomyelitis
(1)
Rotavirus
(2)
Typhoid
(1)
Yellow fever
(4)
Vaccine topics
Target population
Publication date
2015
(23)
2024
(2)
2023
(8)
2022
(8)
2021
(5)
2020
(9)
2019
(26)
2018
(21)
2017
(12)
2016
(28)
2014
(28)
2013
(10)
2012
(3)
2011
(11)
2010
(27)
2009
(17)
2008
(3)
2007
(6)
2006
(7)
2005
(3)
2001
(1)
2000
(1)
1997
(1)
23 results found
2015
∙
STIKO
Background Paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal disease
2015
∙
ACIP
Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) for Use of Serogroup B Meningococcal (MenB) Vaccines in Adolescents and Young Adults (Including College Students)
2015
∙
NACI
Literature Review on Pediatric Fluad® Influenza Vaccine Use in Children 6-72 Months of Age
2015
∙
NACI
NACI Opinion on LAIV Effectiveness in Young Children
2015
∙
NACI
Statement on Seasonal Influenza Vaccine for 2015-2016
2015
∙
NACI
Update on Quadrivalent Meningococcal Vaccines available in Canada
2015
∙
Jessica MacNeil
Considerations for Use of Serogroup B Meningococcal (MenB) Vaccines in Persons at Increased Risk
2015
∙
Haut Conseil de la santé publique
Notice relating to the immunisation recommendations against invasive meningococcal C infections after 24 years, notably in men who have sex with other men (MSM)
2015
∙
Haut Conseil de la santé publique
Notice relating to the minimum compulsory statements when publicising the seasonal flu vaccine FluenzTetra®
2015
∙
Haut Conseil de la santé publique
Opinion concerning the prioritization of the use of antivirals during seasonalinfluenza outbreak
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register